Understanding Corticotropin Releasing Factor Receptor (CRFR) Activation Using Structural Models

被引:0
|
作者
Cordomi, Arnau [1 ]
Liapakis, George [2 ]
Matsoukas, Minos-Timotheos [1 ,3 ]
机构
[1] Univ Autonoma Barcelona, Fac Med, Unitat Bioestat, Lab Med Computac, Bellaterra 08193, Barcelona, Spain
[2] Univ Crete, Fac Med, Dept Pharmacol, Iraklion 71003, Crete, Greece
[3] Univ Patras, Lab Mol Pharmacol, Dept Pharm, Patras 26500, Greece
关键词
Activation; corticotropin releasing factor; family B; GPCR structure; molecular modeling; CRF receptors; PROTEIN-COUPLED RECEPTOR; 2ND TRANSMEMBRANE HELIX; 1ST EXTRACELLULAR DOMAIN; CLASS-B GPCRS; LIGAND-BINDING; ANTAGONIST-BINDING; CRYSTAL-STRUCTURE; NMR STRUCTURE; PEPTIDE; FAMILY;
D O I
10.2174/187446/7210666170110122939
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The corticotropin-releasing factor type 1 and 2 receptors (CRF1R and CRF2R) belong to the secretin-like family, also known as class B1, of G protein-coupled receptors (GPCRs). Several endogenous hormones mediate their responses through the CRF receptors, such as CRF and the urocortins. The structures for the N-terminus extracellular domain of both CRF1R and CRF2R in complex with peptidic ligands were released a few years ago and permitted the study of hormone binding to the orthosteric binding site. Until the crystal structure of the transmembrane domain of human CRF1R in its inactive state bound to an allosteric antagonist became available. Together with the crystal structures of the transmembrane domain of the glucagon receptor (GCGR), they have enabled the structural alignment between the rhodopsin and secretin-like families, which permits the direct comparison of the functional domains in both classes. In this report, we review the current structural landscape, in addition to the knowledge regarding activation of both CRF receptors and the generalization to secretin-like GPCRs in general. Thus, significant effort was put in trying to identify possible analogous microswitches in the class B1, with the hypothesis that both families could maintain a similar arrangement of their functional domain.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [21] Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation
    Hoare, Sam R. J.
    Fleck, Beth A.
    Gross, Raymond S.
    Crowe, Paul D.
    Williams, John P.
    Grigoriadis, Dimitri E.
    MOLECULAR PHARMACOLOGY, 2008, 73 (05) : 1371 - 1380
  • [22] P7, a novel antagonist of corticotropin releasing factor receptor type 1 (CRFR1) screened from phage display library
    Yu, Jinmei
    Zhuo, Rengong
    Peng, Peng
    Liu, Xiaoyan
    Yan, Haitao
    Zhang, Shuzhuo
    Zheng, Jianquan
    Wei, Xiaoli
    Ma, Xiaoyun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 463 (03) : 200 - 204
  • [23] CORTICOTROPIN RELEASING-FACTOR PRODUCES BEHAVIORAL ACTIVATION IN RATS
    SUTTON, RE
    KOOB, GF
    LEMOAL, M
    RIVIER, J
    VALE, W
    NATURE, 1982, 297 (5864) : 331 - 333
  • [24] STRUCTURAL CHARACTERIZATION AND LOCALIZATION OF CORTICOTROPIN-RELEASING FACTOR IN TESTIS
    AUDHYA, T
    HOLLANDER, CS
    SCHLESINGER, DH
    HUTCHINSON, B
    BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 995 (01) : 10 - 16
  • [25] Recent progress in corticotropin-releasing factor receptor agents
    McCarthy, JR
    Heinrichs, SC
    Grigoriadis, DE
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 11 - 20
  • [26] Neuroprotective effects of corticotropin-releasing factor receptor antagonists
    Loddick, SA
    Chalmers, DT
    Yatsushiro, K
    McCulloch, J
    Foster, AC
    Rothwell, NJ
    De Souza, EB
    PHARMACOLOGY OF CEREBRAL ISCHEMIA 1998, 1999, : 371 - 378
  • [27] EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR
    CHEN, RP
    LEWIS, KA
    PERRIN, MH
    VALE, WW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) : 8967 - 8971
  • [28] Recent Advances in Corticotropin-Releasing Factor Receptor Antagonists
    Dzierba, Carolyn D.
    Hartz, Richard A.
    Bronson, Joanne J.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 43, 2008, 43 : 3 - 23
  • [29] Corticotropin releasing factor receptor antagonists for major depressive disorder
    Paez-Pereda, Marcelo
    Hausch, Felix
    Holsboer, Florian
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (04) : 519 - 535
  • [30] RECEPTOR-MEDIATED IMMUNOMODULATION BY CORTICOTROPIN-RELEASING FACTOR
    AUDHYA, T
    JAIN, R
    HOLLANDER, CS
    CELLULAR IMMUNOLOGY, 1991, 134 (01) : 77 - 84